Overview
I am an Advanced Heart Failure and Transplant Cardiologist, and clinical researcher, here at Duke. My research studies outcomes and interventions in patients with Advanced Heart Failure and with heart transplants. Previously, I completed Internal Medicine Residency, and Cardiovascular Medicine and Advanced Heart Failure clinical fellowships here at Duke. I was also an NIH T-32 grant funded Research Fellow at the DCRI. Previously, I completed medical school at the Icahn School of Medicine at Mount Sinai, and was a research fellow in the NIH Medical Research Scholar's program, where I spent 1 year at the National Heart, Lung, and Blood Institute (NHLBI) performing clinical and translational cardiovascular research.
Current Appointments & Affiliations
Assistant Professor of Medicine
·
2025 - Present
Medicine, Cardiology,
Medicine
Recent Publications
Impact of HeartMate 3 left ventricular assist device infection on outcomes following heart transplant.
Journal Article J Heart Lung Transplant · April 2026 BACKGROUND: Infectious complications are common in patients implanted with HeartMate 3 (HM3) left ventricular assist devices (LVAD). Despite these issues, some patients with LVAD-specific infection are ultimately considered for heart transplant (HT). The i ... Full text Link to item CiteOrgan-specific differences in the epidemiology of cytomegalovirus infections in high-risk (cytomegalovirus donor seropositive, recipient seronegative) solid organ transplant recipients with prolonged follow-up: A 10-year experience.
Journal Article Am J Transplant · March 26, 2026 Cytomegalovirus (CMV) causes significant morbidity in CMV donor seropositive/recipient seronegative (D+R-) solid organ transplant recipients, but organ-specific differences in CMV epidemiology and the utility of laboratory surveillance after prophylaxis (S ... Full text Link to item CitePressure points: Hemodynamics and waitlist risk before heart transplant.
Journal Article J Heart Lung Transplant · March 2026 Full text Link to item CiteRecent Grants
Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants with Heart Failure with Preserved Ejection Fraction and Left Ventricular Hypertrophy
Clinical TrialCo Investigator · Awarded by Novo Nordisk, Inc. · 2026 - 2029View All Grants
Education
Icahn School of Medicine at Mount Sinai ·
2017
M.D.
Brown University ·
2011
B.A.